Summarized by Masters of Longevity from TechCrunch.
Report on a vision-restoring retinal implant used in a Stargardt disease patient and its role in a company's broader brain-computer interface strategy.
Key Takeaways
- Science Corporation implanted the PRIMA retinal chip in a Stargardt disease patient as part of an ongoing clinical trial.
- The implanted patient saw a letter in the first rehab session and read a word in the second session.
- PRIMA is a 2 mm by 2 mm subretinal device paired with camera-equipped glasses that conveys high-contrast central vision.
